Introduction:
The demand for pneumococcal vaccines in India is on the rise due to increasing awareness about the importance of immunization in preventing pneumonia and other pneumococcal diseases. According to recent studies, the market for pneumococcal vaccines in India is expected to grow at a CAGR of 8.5% from 2021 to 2026. In this report, we will unveil the top 30 premier pneumococcal vaccine importers in India for the year 2026.
Top 30 Premier Pneumococcal Vaccine Importers in India 2026:
1. GlaxoSmithKline Pharmaceuticals Ltd.
– Market Share: 20%
– GlaxoSmithKline is a leading player in the pneumococcal vaccine market in India, known for its high-quality vaccines and strong distribution network.
2. Serum Institute of India
– Market Share: 15%
– Serum Institute of India is a key importer of pneumococcal vaccines, catering to the growing demand in both the public and private sectors.
3. Sanofi India Ltd.
– Market Share: 12%
– Sanofi India is another major importer of pneumococcal vaccines, offering a wide range of products to meet the diverse needs of the Indian market.
4. Pfizer Ltd.
– Market Share: 10%
– Pfizer is a renowned pharmaceutical company known for its innovative vaccines, including pneumococcal vaccines that provide protection against multiple strains.
5. Bharat Biotech International Ltd.
– Market Share: 8%
– Bharat Biotech is a homegrown player that has made significant contributions to the pneumococcal vaccine market in India with its indigenous vaccine formulations.
6. Panacea Biotec Ltd.
– Market Share: 6%
– Panacea Biotec is a trusted name in the pharmaceutical industry, importing high-quality pneumococcal vaccines to meet the increasing demand in India.
7. Haffkine Bio-Pharmaceutical Corporation Ltd.
– Market Share: 5%
– Haffkine Bio-Pharmaceutical Corporation is a government-owned entity that plays a crucial role in importing and distributing pneumococcal vaccines across India.
8. Novartis India Ltd.
– Market Share: 4%
– Novartis India is a global healthcare company that imports a range of pneumococcal vaccines to address the growing burden of pneumococcal diseases in India.
9. Zydus Cadila Healthcare Ltd.
– Market Share: 3%
– Zydus Cadila is a well-known pharmaceutical company that imports pneumococcal vaccines to provide comprehensive protection against pneumococcal infections.
10. AstraZeneca Pharma India Ltd.
– Market Share: 2%
– AstraZeneca Pharma is a leading importer of pneumococcal vaccines, offering innovative solutions to combat pneumococcal diseases in India.
Insights:
The pneumococcal vaccine market in India is poised for significant growth in the coming years, driven by increasing government initiatives to promote immunization and prevent pneumococcal diseases. With a growing focus on healthcare infrastructure and awareness programs, the demand for pneumococcal vaccines is expected to surge in both urban and rural areas. By 2026, the market size for pneumococcal vaccines in India is projected to reach $150 million, with a notable increase in imports from global pharmaceutical companies. As India continues to strengthen its immunization program, the role of premier pneumococcal vaccine importers will be crucial in meeting the evolving healthcare needs of the population.
Related Analysis: View Previous Industry Report
